<DOC>
	<DOCNO>NCT00002083</DOCNO>
	<brief_summary>To compare effect intranasal peptide T placebo treatment painful peripheral neuropathy associate human immunodeficiency virus ( HIV ) infection .</brief_summary>
	<brief_title>Intranasal Peptide T Treatment Painful Peripheral Neuropathy AIDS</brief_title>
	<detailed_description />
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Peripheral Nervous System Diseases</mesh_term>
	<mesh_term>Nervous System Diseases</mesh_term>
	<criteria>Inclusion Criteria Patients must : Documented HIV1 infection . CD4 count &lt; 500 cells/mm3 . HIV1associated distal symmetrical polyneuropathy , peripheral neuropathy present least 6 week prior study entry . Pain severity least 8 analog scale . Prior zidovudine therapy least previous 3 month ( unless patient show intolerance zidovudine ) . Exclusion Criteria Coexisting Condition : Patients follow symptoms condition exclude : Neuropathy due cause besides HIV infection . Any symptom consistent new active underlying opportunistic infection malignancy could interfere evaluation neuropathy . Clinical evidence new active CNS disease , potentially opportunistic infection neoplasm result HIV infection , could interfere evaluation neuropathy . Other CNS disease ( e.g. , myelopathy ) could complicate evaluation neuropathy . Active lifethreatening illness AIDS . Concurrent Medication : Excluded : Dapsone . Hydralazine . Isoniazid ( INH ) . Current use tricyclic antidepressant , anticonvulsant , clonidine unless patient use drug without change dose least 3 month prior study entry . Narcotics , unless patient use least 6 week prior study entry . Prior Medication : Excluded : ddI ddC past 8 week . Prior peptide T. Prior tricyclic antidepressant , anticonvulsant , clonidine unless use least 3 month without change dose . Other investigational drug within past 30 day . Required : Zidovudine ( intolerance demonstrate ) . Required : Zidovudine least previous 3 month ( unless patient demonstrate intolerance zidovudine ) . Chronic alcohol abuse , current abuse psychoactive recreational drug define DSM IIIR . Patients may regard unreliable study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 1993</verification_date>
	<keyword>Peptide T</keyword>
	<keyword>HIV-1</keyword>
	<keyword>Administration , Intranasal</keyword>
	<keyword>Acquired Immunodeficiency Syndrome</keyword>
	<keyword>Peripheral Nervous System Diseases</keyword>
</DOC>